SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-16-010218
Filing Date
2016-05-20
Accepted
2016-05-20 15:30:15
Documents
13
Period of Report
2016-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_052016.htm 6-K 10103
2 EXHIBIT 99.1 exh_991.htm EX-99.1 286606
3 EXHIBIT 99.2 exh_992.htm EX-99.2 31149
4 GRAPHIC logo.jpg GRAPHIC 18060
5 GRAPHIC graph.jpg GRAPHIC 50484
6 GRAPHIC logo_bw.jpg GRAPHIC 5196
7 GRAPHIC compushare_logo.jpg GRAPHIC 9247
8 GRAPHIC telephone.jpg GRAPHIC 11233
9 GRAPHIC internet.jpg GRAPHIC 10939
10 GRAPHIC electronic.jpg GRAPHIC 11928
11 GRAPHIC qr.jpg GRAPHIC 13020
12 GRAPHIC cross.jpg GRAPHIC 834
13 GRAPHIC date.jpg GRAPHIC 2634
  Complete submission text file 0001171843-16-010218.txt   492516
Mailing Address 5955 AIRPORT ROAD, SUITE 228 MISSISSAUGA A6 L4V 1R9
Business Address 5955 AIRPORT ROAD, SUITE 228 . MISSISSAUGA A6 L4V 1R9 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 161666035
SIC: 2836 Biological Products, (No Diagnostic Substances)